1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA GRIP1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA KIAA0895L CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA RBMS2 CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA CBX8 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA SYT1 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA ZNF414 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA GMFG CTRPv2 pan-cancer AAC 0.19 2e-05
mRNA FBN3 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA DDHD1 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA GPBP1L1 CTRPv2 pan-cancer AAC 0.14 2e-05
Download CSV